These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15969254)

  • 1. Hemodynamic influences of losartan on the brain in hypertensive patients.
    Oku N; Kitagawa K; Imaizumi M; Takasawa M; Piao R; Kimura Y; Kajimoto K; Matsumoto M; Hori M; Hatazawa J
    Hypertens Res; 2005 Jan; 28(1):43-9. PubMed ID: 15969254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
    Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
    Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure lowering with valsartan is associated with maintenance of cerebral blood flow and cerebral perfusion reserve in hypertensive patients with cerebral small vessel disease.
    Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
    J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):85-91. PubMed ID: 20189083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke.
    Nazir FS; Overell JR; Bolster A; Hilditch TE; Reid JL; Lees KR
    J Hypertens; 2004 May; 22(5):989-95. PubMed ID: 15097240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke.
    Moriwaki H; Uno H; Nagakane Y; Hayashida K; Miyashita K; Naritomi H
    J Hum Hypertens; 2004 Oct; 18(10):693-9. PubMed ID: 15129230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral hemodynamics after short- and long-term reduction in blood pressure in mild and moderate hypertension.
    Zhang R; Witkowski S; Fu Q; Claassen JA; Levine BD
    Hypertension; 2007 May; 49(5):1149-55. PubMed ID: 17353511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
    Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
    Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiproteinuric effect of losartan is systemic blood pressure dependent.
    Crowe AV; Howse M; Vinjamuri S; Kemp GJ; Williams PS
    Nephrol Dial Transplant; 2003 Oct; 18(10):2160-4. PubMed ID: 13679496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral perfusion reserve in patients with previous minor stroke.
    Hatazawa J; Shimosegawa E; Osaki Y; Ibaraki M; Oku N; Hasegawa S; Nagata K; Hirata Y; Miura Y
    Stroke; 2004 Sep; 35(9):2117-22. PubMed ID: 15256675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
    Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
    Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects.
    Lipsitz LA; Gagnon M; Vyas M; Iloputaife I; Kiely DK; Sorond F; Serrador J; Cheng DM; Babikian V; Cupples LA
    Hypertension; 2005 Feb; 45(2):216-21. PubMed ID: 15655124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal imaging in rats reveals impaired neurovascular coupling in sustained hypertension.
    Calcinaghi N; Wyss MT; Jolivet R; Singh A; Keller AL; Winnik S; Fritschy JM; Buck A; Matter CM; Weber B
    Stroke; 2013 Jul; 44(7):1957-64. PubMed ID: 23735955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial).
    Joshi SR; Yeolekar ME; Tripathi KK; Giri J; Maity AK; Chopda M; Gujarathi S; Maroli S; Maity A;
    J Assoc Physicians India; 2004 Mar; 52():189-95. PubMed ID: 15636307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of long-term antihypertensive therapy with losartan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors (AWARE observational study)].
    Schrader J; Lüders S; Diener HC; Haller H; Schmieder RE; Wahle K; Smolka W; Jung C; Bestehorn K
    Med Klin (Munich); 2008 Jul; 103(7):491-9. PubMed ID: 18604484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade inflammation and ambulatory blood pressure response to antihypertensive treatment: the ALPHABET study.
    Fukutomi M; Hoshide S; Eguchi K; Watanabe T; Kario K
    Am J Hypertens; 2013 Jun; 26(6):784-92. PubMed ID: 23446957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.